AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

KALA BIO, Inc. Director's Dealing 2017

Jul 20, 2017

35091_dirs_2017-07-19_7e4aa24f-e7a8-49d2-8624-9761d7a5158d.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Kala Pharmaceuticals, Inc. (KALA)
CIK: 0001479419
Period of Report: 2017-07-19

Reporting Person: Hanes Justin (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	601923	Direct